Hong Kong-based Haitong International Securities Group (Haitong), one of the largest Chinese investment banks in offshore markets, has led the initial close of Series B financing in Boston-based biotech research firm Orig3n.
Start your deal-making journey now!
Subscribe now to enjoy unlimited access at just $59.
Premium coverage on private equity, venture capital, and startups in Asia.
Exclusive scoops from our reporters in nine key markets.
In-depth interviews with industry leaders shaping the ecosystem.
Already a Subscriber? Log in
Contact us for corporate subscriptions at subs@dealstreetasia.com
